Holdings
Rhenman & Partners Asset Management AB
As of Jun 30, 2026, Rhenman & Partners Asset Management AB reported 87 positions worth US$936M. Largest: Unitedhealth Group Incorporated, Cvs Health Corporation and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Unitedhealth Group Incorporated | 93,600 | US$38.9M | +48,100 | Jun 30, 2026 |
| Cvs Health Corporation | 279K | US$28.9M | −57,126 | Jun 30, 2026 |
| Merck & Company, Inc. | 214K | US$27.4M | new | Jun 30, 2026 |
| Eli Lilly And Company | 22,315 | US$26.8M | −11,400 | Jun 30, 2026 |
| Abbvie Inc. | 96,775 | US$24.4M | +25,200 | Jun 30, 2026 |
| Alignment Healthcare, Inc. | 997K | US$23.7M | −56,367 | Jun 30, 2026 |
| Edwards Lifesciences Corporation | 260K | US$23.5M | +97,000 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 178K | US$22.5M | +10,500 | Jun 30, 2026 |
| Biogen Inc. | 94,850 | US$20.5M | −14,250 | Jun 30, 2026 |
| Stryker Corporation | 65,000 | US$20.5M | +17,200 | Jun 30, 2026 |